namu

Updated September 2026 Wave Life Sciences Inc. (NASDAQ: WVE) is attracting growing attention from U.S. biotech investors for a reason: the company is no longer defined by a single rare-disease program. Wave now has several potentially valuable clinical and preclinical assets, including: WVE-007 , an investigational obesity and cardiometabolic treatment WVE-006 , an RNA editing candidate for alpha-1 antitrypsin deficiency WVE-008 , an RNA editing program for PNPLA3-related liver disease WVE-N531 , an exon-skipping candidate for Duchenne muscular dystrophy WVE-003 , an allele-selective candidate for Huntington’s disease A broad research collaboration with GSK The biggest source of investor interest in 2026 has been WVE-007. Unlike GLP-1 medicines that primarily reduce appetite and food intake, WVE-007 is designed to change body composition by targeting fat biology while preserving muscle. That is a compel...

Credo Technology Group Holding Ltd. (NASDAQ: CRDO) has emerged as one of the fastest-growing beneficiaries of the artificial intelligence infrastructure boom. The company reported another quarter of triple-digit year-over-year revenue growth, supported by strong demand for high-speed connectivity solutions used inside AI data centers. However, despite beating revenue and earnings estimates, CRDO stock fell sharply after the report. Why did Credo Technology stock decline even though the company delivered strong earnings? This article examines the latest CRDO earnings report, Credo Technology’s AI data center opportunity, Active Electrical Cable growth, optical business outlook, valuation, major risks, and long-term CRDO stock forecast . CRDO Investment Summary Fiscal Q1 2027 revenue increased 114.7% year over year. Fiscal Q2 revenue guidance implies continued strong growth. AEC remains a major growth eng...

If you have ever checked the Chinese yuan exchange rate , sent money to China, traded currencies, or done business with a Chinese company, you may have encountered three different terms: RMB, CNY, and CNH . They are closely related, but they do not mean exactly the same thing. The easiest way to understand the difference is this: RMB is the name of China's currency, CNY generally refers to the onshore yuan, and CNH refers to yuan traded in offshore markets. The distinction becomes especially important when comparing USD/CNY vs. USD/CNH exchange rates , because the two rates can differ even though both represent the Chinese yuan. CNY vs. CNH vs. RMB at a Glance RMB = Renminbi, the official name of China's currency Yuan = The basic unit of the renminbi CNY = ISO 4217 currency code for the Chinese yuan; commonly used for the onshore market CNH = Market convention for offshore renminbi, especially in international FX markets Key Difference = CNY and CN...